Skip to main content
. 2011 Apr 20;34(5):1109–1113. doi: 10.2337/dc10-2108

Table 2.

ORs for association between gestational age at birth (1973–1979) and diabetes medication prescription in young adulthood (ages 25.5–37.0 years)

Medications (ATC code) (outcome variable) Unadjusted
Adjusted model 1*
Adjusted model 2
OR (95% CI) OR (95% CI) OR (95% CI)
Any diabetes medications (A10)
 Gestational age (predictor variable) (weeks)
  <37 1.20 (1.08–1.33) 1.16 (1.04–1.28) 1.13 (1.02–1.26)
  23–28 1.56 (0.77–3.18) 1.54 (0.76–3.15) 1.53 (0.75–3.11)
  29–34 1.13 (0.93–1.36) 1.09 (0.90–1.32) 1.05 (0.87–1.28)
  35–36 1.22 (1.08–1.38) 1.18 (1.04–1.33) 1.16 (1.03–1.31)
  37–42 1.00 1.00 1.00
  ≥43 1.07 (0.94–1.21) 1.03 (0.90–1.17) 0.98 (0.86–1.11)
Any insulin (A10A) without oral diabetes medications (A10B)
 Gestational age (predictor variable) (weeks)
  <37 1.26 (1.12–1.43) 1.24 (1.09–1.40) 1.22 (1.08–1.39)
  23–28 1.53 (0.64–3.70) 1.52 (0.63–3.67) 1.51 (0.63–3.65)
  29–34 1.28 (1.03–1.61) 1.26 (1.00–1.57) 1.25 (1.00–1.56)
  35–36 1.25 (1.08–1.45) 1.22 (1.05–1.42) 1.21 (1.04–1.40)
  37–42 1.00 1.00 1.00
  ≥43 0.90 (0.76–1.08) 0.90 (0.75–1.07) 0.90 (0.76–1.08)

*Adjusted for age, sex, maternal age at delivery, maternal marital status, maternal education, family income, and maternal prescription of diabetes medications during the follow-up period (1 July 2005 through 31 December 2009).

†Adjusted for the same variables included in adjusted model 1 and fetal growth.